It became clear that endometrial cancer was part of LS [5] and the revised Amsterdam II clinical criteria were agreed, including endometrial cancer as an affected phenotype [6] and consistent with path_MSH6 being a cause of LS. The gene discussed is MSH6; the disease is endometrial cancer.